Dr. Carolyn Joyce Van Why, MD

Dr. Van Why practices at Cardiology Consultants of Philadelphia in Philadelphia, Pennsylvania.

Dr. Van Why's NPI, 1093987984, was assigned on March 31, 2008. Dr. Van Why graduated from Johns Hopkins University School of Medicine in 2003. Dr. Van Why holds Pennsylvania license MD442673.

Dr. Van Why's primary practice is Cardiology Consultants of Philadelphia, at 207-9 N Broad St, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 463-5333.

Dr. Van Why's primary practice is Cardiology Consultants of Philadelphia in Philadelphia, Pennsylvania. Dr. Van Why is also affiliated with Jefferson Abington Hospital. The medical group on file is Cardiology Consultants of Philadelphia. Dmand AI also links Dr. Van Why to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Van Why practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Van Why's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Van Why is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Van Why is licensed in Pennsylvania.

CMS data shows 5,373 Medicare services from Dr. Van Why across 29 procedure codes in 2024, for 1,462 Medicare patients. Medicare paid $598,745 for them.

CMS counts 1,462 Medicare patients who saw Dr. Van Why in 2024. The largest group is 75 to 84, with 622 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Van Why's median patient age at 75, with 53% women.

In 2024, Dr. Van Why wrote 6,445 Medicare Part D claims for 704 patients. 85% of them were for generic drugs. CMS names the drug for 6,182 of them, across 56 drugs with 11 or more claims each, at $924,827 in total drug cost. In 2023, CMS named 5,778 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Van Why for performance year 2024, reported as part of a group. Dr. Van Why accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 140 general payments to Dr. Van Why from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Pfizer Inc. paid the most, $483.

Dr. Van Why graduated from Johns Hopkins University School of Medicine in 2003.